Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3350663 | Human Immunology | 2012 | 4 Pages |
Abstract
The impact of HLA-DPB1 mismatches after unrelated hematopoietic stem cell transplantation (HSCT) remains controversial. We retrospectively analyzed the impact of permissive/non-permissive HLA-DPB1 mismatches on the outcome of 141 patients who underwent 10/10 HLA allelic-matched unrelated HSCT. Each pair was classified according to the 3 (TCE3) and 4-group (TCE4) algorithm based on DPB1 alleles immunogenicity. Outcome analysis revealed that TCE3 and TCE4 non-permissive HLA-DPB1 disparities were not associated with worsened overall survival, relapse risk neither risk of acute GvHD. Overall, this single center retrospective study does not confirm the adverse prognostic of non-permissive HLA-DPB1 mismatches.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Cyrille Touzeau, Katia Gagne, Véronique Sébille, Patricia Herry, Patrice Chevallier, Gilles Folléa, Anne Devys, Philippe Moreau, Mohamad Mohty, Anne Cesbron Gautier,